Table of Content
- Vol.31, No.1, 2023
- Vol.31, No.2, 2023
- Vol.31, No.3, 2023
- Vol.31, No.4, 2023
- Vol.31, No.5, 2023
- Vol.31, No.6, 2023
- Vol.30, No.1, 2022
- Vol.30, No.2, 2022
- Vol.30, No.3, 2022
- Vol.30, No.4, 2022
- Vol.30, No.5, 2022
- Vol.30, No.6, 2022
- Vol.29, No.1, 2021
- Vol.29, No.2, 2021
- Vol.29, No.3, 2021
- Vol.29, No.4, 2021
- Vol.29, No.5, 2021
- Vol.29, No.6, 2021
- Vol.28, No.1, 2020
- Vol.28, No.2, 2020
- Vol.28, No.3, 2020
- Vol.28, No.4, 2020
- Vol.28, No.5, 2020
- Vol.28, No.6, 2020
- Vol.28, No.7-8, 2020
- Vol.28, No.9, 2020
- Vol.27, No.1, 2019
- Vol.27, No.2, 2019
- Vol.27, No.3, 2019
- Vol.27, No.4, 2019
- Vol.27, No.5, 2019
- Vol.27, No.6, 2019
- Vol.27, No.7, 2019
- Vol.27, No.8, 2019
- Vol.27, No.9, 2019
Editors-in-Chief
-
Edward Chu
Albert Einstein College of Medicine, USA
Interests: cancer pharmacology and drug development
-
Enrico Mini
University of Florence Florence, ITALY
Interests: the mechanisms of tumor drug resistance, in particular to antimetabolites and metal-based drugs, cancer pharmacogenomics and pharmacogenetics, and controlled clinical trials in gastrointestinal cancers
-
Kazuo Umezawa
Aichi Medical University, JAPAN
Interests: CPR, resuscitation, critical care medicine, intensive care medicine, hypothermia, emergency management, emergency treatment, sepsis, ventilation, ICU
Editorial Board Members
-
Jinhua Wang
National Center for Pharmaceutical Screening, Institute of Materia Medica, CHINA
Interests: the mechanism and drug targets of cancers
-
Makoto Kawatani
RIKEN Center for Sustainable Resource Science (CSRS), JAPAN
Interests: chemical biology, drug development and cancer research
-
Nocentini Giuseppe
University of Perugia, ITALY
Interests: pharmacology, immunotoxicology and pharmacoimmunology
-
Hiroyuki Osada
RIKEN Center for Sustainable Resource Science (CSRS), JAPAN
Interests: chemical biology research
-
Wunchana Seubwai
Khon Kaen University, THAILAND
Interests: cancer biology, cell signaling,cell culture, immunohistochemistry, apoptosis, cell proliferation, biochemistry, cancer cell biology, molecular cell biology, gene expression
-
Ryouichi Horie
Kitasato University, JAPAN
Interests: molecular hematology, medical sciences
-
David A. Gewirtz
Virginia Commonwealth University, USA
Interests: autophagy, cell biology, programmed cell death, apoptosis and senescence
-
Aamir Ahmad
University of Alabama at Birmingham, USA
Interests: cancer metastasis, drug resistance, miRNA and cancer health disparity
-
Isao Momose
Institute of Microbial Chemistry, JAPAN
Interests: bioorganic chemistry; applied biochemistry and applied microbiology
-
Yohko Yamazaki
Institute of Microbial Chemistry, JAPAN
Interests: androgen receptors, prostate cancer, anticancer drugs and phospholipid remodeling
-
Luca Maria Munaron
University of Torino, ITALY
Interests: tumor-derivedendothelial cells, drugdelivering against tumor vascularization and Bone vascularization and biomaterials
-
Petar Ozretić
Laboratory for Hereditary Cancer, Ruđer Bošković Institute (RBI), CROATIA
Interests: cancer genetics, epigenetics, bioinformatics, biostatistics and molecular oncology
-
Sanjay Gupta
Case Western Reserve University, USA
Interests: cancer biomarkers, cancer therapeutics and drug repurposing and cancer stem cells research
-
Hong Shen
Xiangya Hospital, Central South University, CHINA
Interests: tumor microenvironment, immunotherapy, tumor metabolism, epigenetic therapy, single-cell sequencing, cell proliferation, tumor metastasis
-
Jianxun Jim Song
Texas A&M University Health Science Center, USA
Interests: T cell biology, immunotherapy, stem cells, cancer, autoimmunity, cell metabolism, signal transduction
-
Ning Wei
Montefiore Einstein Cancer Center, USA
Interests: cancer pharmacology and drug discovery
-
Tao Liu
Lowy Cancer Research Centre, AUSTRALIA
Interests: oncology and carcinogenesis, cancer cell biology, cancer genetics, cancer therapy
-
Jinhui Liu
The First Affiliated Hospital of Nanjing Medical University, CHINA
Interests: biomarker, prognostic model, non-coding RNA, machine learning, bioinformatics, immunology
-
Mohammad Oves
King Abdulaziz University, SAUDI ARABIA
Interests: multidrug resistance, antimicrobial agents and
nanomaterials bio-fabrication, biofilm, chromium reduction and phosphate solubilization microbe
-
Mohammad Rahimi-Gorji
Ghent University, BELGIUM
Interests: cancer and tumor modeling, drug delivery, intraperitoneal chemotherapy, CFD simulation of drug delivery, biomedical modeling
-
Xu Dong Zhang
University of Newcastle, AUSTRALIA
Interests: melanoma, pancreatic, colorectal & rare cancers
-
Chunlin Ou
Xiangya Hospital, Central South University, CHINA
Interests: the regulatory mechanism of non-coding RNAs in cancers, clinical application of mRNA vaccine in cancers.
-
Yingying Lin
Shanghai Jiaotong University, CHINA
Interests: tumor microenvironment, protease, glioma
-
Stefania Nobili
University of Florence, ITALY
Interests: pharmacology, applied pharmacology
-
Hardeep Singh Tuli
Maharishi Markandeshwar University, INDIA
Interests: cordyceps, nanoparticles, cancer biology, microbial biotechnology, cell cycle, therapeutics
-
Ciro Isidoro
Università del Piemonte Orientale, ITALY
Interests: cancer biology, autophagy, cell death, cell biology, cancer research, apoptosis, cell proliferation
-
Antonio Ruggiero
Fondazione Policlinico Universitario Gemelli IRCCS, ITALY
Interests: pediatric clinical trials, clinical pharmacology of antineoplastic drugs, pain therapy and pediatric drugs
-
Francesca De Felice
Sapienza University of Rome, ITALY
Interests: gastrointestinal cancers, head and neck cancers, gynecological cancers, machine learning data analysis, survival analysis
-
William CHO
Queen Elizabeth Hospital, HONG KONG
Interests: molecular biology, proteomics, genomics, immunology, bioinformatics, next-generation sequencing
-
Ammad Ahmad Farooqi
Institute of Biomedical and Genetic Engineering, PAKISTAN
Interests: cancer genetics and therapeutics, targeting of oncogenic signaling pathways using natural products, restoration of apoptotic pathway in resistant cancers
-
Bahil Ghanim
Karl Landsteiner University of Health Sciences, AUSTRIA
Interests: biomarkers, thoracic surgery, lung cancer, mesothelioma, minimal invasive surgery and solitary fibrous tumor of the lung
-
Yong Teng
Emory University School of Medicine, USA
Interests: tumor microenvironment, tumor metabolism, and metastasis with an emphasis on molecular determinants
-
Marina Kriajevska
University of Leicester, UK
Interests: cell signaling, bladder cancer
-
Tao Li
Qilu Hospital, Shandong University, CHINA
Interests: the biology and treatment of Hepatobiliary tumors
-
Alfons Navarro Ponz
University of Barcelona, SPAIN
Interests: non-coding RNAs in solid and hematologic cancers, including colorectal cancer, non-small-cell lung cancer, Hodgkin lymphoma, acute myeloid leukemia, and multiple myeloma
-
Tianhui Chen
Zhejiang Cancer Hospital, CHINA
Interests: clinical epidemiology, molecular epidemiology, genetic epidemiology of familial cancer (colorectal cancer, breast cancer, ovarian cancer, pancreatic cancer)
-
Nobuyuki Horita
Yokohama City University Hospital, JAPAN
Interests: pulmonary disease, meta-analysis, propensity score matching, and survival analysis
-
Constantinos Mikelis
University of Patras, GREECE
Interests: investigating the role of the small GTPase RhoA on developmental and tumor-induced angiogenesis, lymphangiogenesis, on the role of endothelial RhoA on cancer cell trans-endothelial migration, signaling circuits, genetic alterations taking place in the endothelium upon incorporation of cancer-derived exosomes, as part of the pre-metastatic niche
-
Giovanni Monteleone
University of Rome Tor Vergata, ITALY
Interests: gastroenterology, cancer immunity and immunotherapy, liver and clinical research
-
Serge Weis
Johannes Kepler University, AUSTRIA
Interests: neurodegeneration,biological psychiatry, neuro-oncology, neuro-AIDS, temporal lobe epilepsy, neuromuscular, drug abuse and brain pathology, stroke and chlamydia, development of the human brain,sexual dimorphism, cerebral asymmetries, neuro-imaging and morphometry in micronanatomic neurosurgery, pituitary gland
-
Chin-Hsiao Tseng
National Taiwan University Hospital, TAIWAN
Interests: diabetes, arsenic-related health hazards, cancer issues related to diabetes and antidiabetic drugs
-
Roberto Passera
University of Torino, AOU Città della Salute e della Scienza (Molinette Hospital), ITALY
Interests: cancer clinical epidemiology and biostatistics, systematic reviews and meta-analyses in surgical oncology, chemo- and immunochemo- regimens in onco-hematology, new biomarkers for prostate cancer, pharmacokinetic and pharmacodynamic trials in oncology
-
Calvin Sze Hang Ng
Chinese University of Hong Kong, HONG KONG
Interests: lung cancer, tumor biology, metastasis, video-assisted thoracic surgey, clinical oncology
-
Shuyu Zhang
Sichuan University, CHINA
Interests: tumor radiosensitivity mechanisms and nuclear radiation damage prevention strategies
-
Manuel Graeber
The University of Sydney, AUSTRALIA
Interests: brain tumours, glioblastoma, microglia, brain macrophages, tumour microenvironment, neurogenetics
-
Alexander Shtil
Blokhin Cancer Center, RUSSIA
Interests: mechanisms of tumor cell death, drug resistance, antitumor drug design
-
Sebastiano Mercadante
La Maddalena Cancer Center, ITALY
Interests: cancer pain, palliative medicine, anesthesiology
-
George Gong CHEN
The Chinese University of Hong Kong, HONG KONG
Interests: head and neck cancers, especially thyroid cancer and laryngeal cancer
-
Sandra E. Ghayad
Aix-Marseille Université, FRANCE
Interests: cancer cells; cancer therapy; tumors thrombosis; senescence; exosomes; microvesicles
-
Cheorl-Ho Kim
Sungkyunkwan University, KOREA
Interests: innate immunity; microbe-host interasction; angiogensis; differentiation; invasion; ethnopharmcology; molecular and cellular glycobiology; cancer research
-
Wenxue Ma
University of California, USA
Interests: cancer stem cell (CSC), cancer immunotherapy, antigen presentation, tumor neoantigens, Cytotoxic T-Lymphocytes (CTLs), tumor-infiltrating lymphocytes (TILs), dug delivery with nanotechnology (Nanomedicine), targeted cancer therapy, circulating tumor cell (CTC), biomarkers
-
Luca Bertolaccini
European Institute of Oncology IRCCS, ITALY
Interests: lung cancer surgery, minimally invasive thoracic surgery, thoracic oncology, biostatistics
-
Leonardo Oliveira Reis
Pontifical Catholic University of Campinas, BRAZIL
Interests: prostate cancer; urologic surgical; bladder cancer; cancer diagnostics; urologic oncology; cryosurgery; translational research; evidence based medicine; hydronephrosis
-
Ying Liu
Qingdao University, CHINA
Interests: basic and applied research on nuclear receptor signal transduction, protein post-translational modification, identification of tumor biomarkers, and bioinformatics
-
Maria Caffo
University of Messina, ITALY
Interests: glioblastoma multiforme (GBM), astrocytoma, medulloblastoma, neuroradiology, magnetic resonance, glioma, molecular oncology, meningioma,neurosurgery
-
Hooman Yarmohammadi
Memorial Sloan-Kettering Cancer Center, USA
Interests: diagnostic radiology; diagnosis; pancreatic cancer; interventional radiology; endovascular procedures; tumors; lung; cancer biology; animal studies
-
Consolato Sergi
University of Ottawa, CANADA
Interests: biology and pathology of the cardiovascular, gastrointestinal System and gut, bile microbiome, bone cell biology, pediatric pathology with nanotech applications for oncology
-
Xiaofang Che
The First Hospital of China Medical University, CHINA
Interests: tumor microenvironment, hypoxia, immunology, cancer, proliferation, drug resistance, metastasis, exosome, non-cording RNA, m6A methylation, post-translational modification, biomarker
-
Jing He
Guangzhou Women and Children's Medical Center, CHINA
Interests: cancer genetics, cancer epidemiology, molecular epidemiology, cancer therapy, signal transduction, pediatric oncology, evidence-based medicine (meta-analysis), molecular biology
-
Pierlorenzo Pallante
IEOS, Consiglio Nazionale delle Ricerche (CNR), ITALY
Interests: non-coding RNA, cancer biology, biomarkers, cell biology, cancer therapy, prognosis, pharmacology, cancer chemotherapy, translational research in the field of lung and colorectal oncology
-
Hasan Mahmud Reza
North South University, BANGLADESH
Interests: pharmaceutical dosage form development, pharmacological studies with natural products and available molecules using animal disease models, molecular biology and biochemistry, cell culture
Early Career Editorial Board Member
-
Romeo Patini
Catholic university of Sacred Heart Rome, ITALY
Interests: molecular biology, biological fluids proteomics
-
Chavda Vivek Prakash Bhai
L.M. College of Pharmacy, INDIA
Interests: complex injectable, biologics, immunotherapy and vaccine
-
Emanuele Perrone
Fondazione Policlinico Agostino Gemelli IRCCS, ITALY
Interests: gynecology oncology, cervical, ovarian and endometrial cancer
-
Hao Zhang
Chongqing Medical University, CHINA
Interests: tumor microenvironment; cancer immunotherapy; small molecule drug; molecular mechanism; bioinformatics; target therapy; signal transduction
-
Jiyoon Bu
INHA University, KOREA
Interests: drug delivery, nano engineering, liquid biopsy, immunotherapy
-
Marzia Di Donato
University of Campania “L.Vanvitelli”, ITALY
Interests: androgens/androgen receptor axis, steroids; growth factors, receptors, signal transduction, cell cycle, invasiveness, breast and prostate cancer, tumor microenvironment, cell differentiation, cell biology, migration, cell proliferation
-
Yaying Sun
Huashan Hospital, CHINA
Interests: multi-organic crosstalk in terms of musculoskeletal and immune system, development of novel nanomedicine delivery system, prognostic factors and predictive model establishment of different cancers
-
Fernando Mendes
Instituto Politécnico de Coimbra, PORTUGAL
Interests: lung cancer, lymphoma, blood bank, immunhematology, cancer treatement, radiotherapy, immune system, forsman blood group
-
Gerardo Cazzato
University of Bari "Aldo Moro", ITALY
Interests: lung diseases; mediastinal diseases; mesothelioma; skin; thoracic diseases; melanoma; dermatopathology; clinical dermatology; squamous cell carcinoma
-
Ziheng Wang
Nantong University, CHINA
Interests: bioinformatics analysis; clinical problems with machine learning; oncology using single-cell omics strategies; basic and clinical research studies; molecular pathology; etiology and pathogenesis; biomarkers; genomics; transcriptome; proteomics; metabonomics; prognosis
-
Roberto Cuomo
University of Siena, ITALY
Interests: melanoma, squamous cell carcinoma, basal cell carcinoma, skin cancer, rare skin cancer, breast cancer
-
Le Su
Jacksonville State University, USA
Interests: epigenetics, childhood cancer (molecular and cellular basis of childhood sarcomas), targeted therapy
Editorial Advisory Board
-
L. J. Appleman
University of Pittsburgh, USA
Interests: tumor immunology, clinical trial of an autologous dendritic cell vaccine, cancer immunotherapy
-
N. Bahary
University of Pittsburgh, USA
Interests: oncologists diagnose, cancer surgeons, or surgical oncologists, remove tumors, while medical oncologists treat cancers with chemotherapy, gastrointestinal cancer
-
J. R. Bertino
Rutgers Cancer Institute of New Jersey, USA
Interests: cancer biology, lymphomas, antimetabolites
-
J. H. Beumer
Hillman Cancer Center, USA
Interests: pharmacology, toxicology
-
M. Boyiadzis
University of Pittsburgh, USA
Interests: internal medicine, hematology/oncology, medical oncology
-
Y.-C. Cheng
Yale University School of Medicine, USA
Interests: pharmacology, antiviral drugs against HBV, HIV, EBV, and HCV, as well as the discovery of antivirals with unique mode of action against those viruses.
-
M. S. Copur
University of Nebraska, USA
Interests: medical oncology, hematology
-
A. Krishnamurthy
University of Pittsburgh, USA
Interests: diagnosis and multidisciplinary management of gastrointestinal (GI) cancers
-
Y. Li
Sorrento Therapeutics, USA
Interests: tumor immunology, molecular biology, medical genetics and clinical medicine
-
M. Rudek
Johns Hopkins University, USA
Interests: clinical pharmacology of anticancer agents; early phase drug development; drug tolerability in cancer patients with HIV/AIDS; drug tolerability in cancer patients with organ dysfunction; blood-brain barrier penetration of drugs.
-
J. C. Schmitz
University of Pittsburgh, USA
Interests: pharmacodynamic, the mechanism(s) of action of quassinoids on colorectal cancer cells and tumors
-
L. Zhang
University of Pittsburgh, USA
Interests: pharmacology and chemical Biology
-
A. H. Calvert
University of Newcastle upon Tyne, UK
Interests: tumor biology
-
A. Di Paolo
University of Pisa, ITALY
Interests: pharmacology, clinical pharmacokinetics and PK/PD of antineoplastic and antiinfective drugs
-
D. Longley
Queen’s University, UK
Interests: apoptosis proteins, birinapant, poptosis
-
J. Robert
Université de Bordeaux, FRANCE
Interests: pharmacocinétique, métabolisme et résistance, pharmacologie cellulaire et moléculaire, pharmacogénétique
-
J. H. M. Schellens
Netherlands Cancer Institute, the Netherlands
Interests: clinical pharmacology
-
P. Workman
CRC Center for Cancer Therapeutics, UK
Interests: drug discovery, molecular pharmacology and chemical biology approaches
-
A. Deguchi
Tokyo Women’s Medical University, JAPAN
Interests: pharmacology, cancer research
-
X. Ding
Nanjing Medical University, CHINA
Interests: digestive diseases
-
S. Gantsev
Bashkirian State Medical University, RUSSIAN
Interests: pharmacology
-
Y. Horiguchi
Tokyo Medical University, JAPAN
Interests: biomaterials and bioengineering
-
M. Imoto
Keio University, JAPAN
Interests: nanotechnology, materials, chemical biology
-
H. Kakeya
Kyoto University, JAPAN
Interests: chemical biology
-
M. Kawatani
RIKEN, JAPAN
Interests: interdisciplinary science & engineering, biological sciences
-
E. Kikuchi
Keio University, JAPAN
Interests: neuropsychiatry
-
K. P. Kim
University of Ulsan College of Medicine, KOREA
Interests: pre-medicine, clinical pharmacology
-
T. W. Kim
University of Ulsan College of Medicine, KOREA
Interests: medicine
-
Y. Lin
Aichi Medical University, JAPAN
Interests: pancreatic cancer, gastric cancer, epidemiologic studies, esophageal cancer
-
J. Neuzil
Griffith University, Gold Coast Campus, AUSTRALIA
Interests: medical microbiology, oncology and carcinogenesis
-
O. Ohno
Kogakuin University, JAPAN
Interests: immunology
-
T. Ohsugi
Rakuno Gakuen University, JAPAN
Interests: genetically modified mice, MNVmouse norovirusspecific pathogen-freemicrobiological monitoring HTLV-1 animal modeltaxTransgenic miceATLL
-
M. Oya
Keio University, JAPAN
Interests: urology
-
M. Ozaki
Hokkaido University, JAPAN
Interests: biomedical imaging, oxidative stress, non-alcoholic fatty liver disease
-
Y. Sasazawa
Juntendo University, JAPAN
Interests: proteomics and biomolecular science
-
K. Sidthipong
Mahidol University, THAILAND
Interests: biology, chemistry, bioorganic & medicinal chemistry letters
-
S. Simizu
Keio University, JAPAN
Interests: cancer, molecular target therapy, inflammation, chemical biology
-
M. Takeiri
Ivy Cosmetics, JAPAN
Interests: osteoclasts
-
E. Tashiro
Showa Pharmaceutical University, JAPAN
Interests: nature chemical biology
-
T. Ueno
Tsukuba University, JAPAN
Interests: materials science
-
M. Yamamoto
Waseda University, JAPAN
Interests: infrared, FTIR analysis, infrared spectrophotom